Hi Yehudi,
Very good conference, around 190 attended all up. Megan gave a fantastic presentation and in talking to other attendees over drinks afterwards there was a feeling of interest from those who did not hold the stock to look at it more closely now that the first level of the OPT trial has been de-risked somewhat (VEGF C/D is first in human after all)...
Points I had reinforced by the presentation were:
- 1.8mil people (OECD world) are impacted by WetAMD, this is expected to DOUBLE by 2020.
- approx a 10bn market opp worldwide with the majority of drug being off label Avastin (vegfa chemo drug).
- Do your own research on how we stack up vs. the Fovista combo w Lucentis - makes one feel good.
- We also have a possible solution to the Diabetic Macular Edema (DME) market, this could be a value add for OPT302 not yet considered. Megan did mention it was something they're looking at as theyve got a validated pathway now; this could be a while off however.
Lots to like, I would like to see more consolidation at these prices, and don't have a short term crystal ball but I imagine there are a few people with FOMO on the sidelines...
As always, the above is my own opinion, make sure you read all the OPT anns and do your own DD.
Cheers,
Sol
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea reports positive data from Phase 1 wet AMD Trial-OPT.AX
Ann: Opthea reports positive data from Phase 1 wet AMD Trial-OPT.AX, page-10
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
47.5¢ |
Change
-0.020(4.04%) |
Mkt cap ! $584.7M |
Open | High | Low | Value | Volume |
49.5¢ | 50.8¢ | 47.5¢ | $4.304M | 9.050M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 29597 | 47.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.5¢ | 15044 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 27497 | 0.475 |
4 | 69173 | 0.470 |
1 | 15044 | 0.465 |
1 | 18645 | 0.460 |
3 | 20931 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.485 | 15044 | 2 |
0.490 | 15044 | 1 |
0.500 | 1540 | 1 |
0.505 | 1970 | 1 |
0.510 | 66230 | 3 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online